Dechra Pharmaceuticals Share Price (DPH)

1,358.00 +35.00 (+2.65%) delayed: 12:57PM BST
Bid price 1,356.00 Open price 1,319.00
Ask price 1,360.00 Prev close 1,323.00
High price 1,357.00 Spread 0.29%
Low price 1,319.00 Volume 59,159

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 1,358.00 Net Gearing (%) 43.69
Market Capitalisation (£m) 1,231.75 Gross Gearing (%) 50.67
Shares in issue (m) 92.75 Debt Ratio 44.06
P/E Ratio 94.86 Debt-to-Equity Ratio 0.77
Total dividends per share (p) 18.46 Assets / Equity Ratio 2.03
Dividend Yield (%) 1.39 Price to book value 4.45
Dividend cover (x) 1.25 ROCE (%) 2.94
Earning per share (p) 14.00 EPS Growth (%) -36.77
52 week high / low 1,438.50 / 811.00 DPS Growth (%) 8.97

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
06/06/2016 BUY Tony Rice NED 20,000
18/03/2016 EXR Ian Page CEO 87,905
18/03/2016 SEXR Ian Page CEO 41,440
18/03/2016 EXR Tony Griffin ED 32,027
09/09/2015 EXR Anne-Françoise Nesmes RES 38,859

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

08:00 21/09/2016

2016 Annual Financial Report

/* */ RNS Number : 3845K Dechra Pharmaceuticals PLC 21 September 2016     Wednesday, 21 September 2016     Dechra ® Pharmaceuticals PLC (the Company) Annual Financial Report     The Company announced...

15:10 19/09/2016

Director/PDMR Shareholding

/* */ RNS Number : 2354K Dechra Pharmaceuticals PLC 19 September 2016     The announcement below replaces an announcement released in error on 15 September 2016 under RNS number 9802J. That announcement should have been released on 19 September 2016 in relation to...

07:22 16/09/2016

Dechra to acquire Apex Laboratories

Dechra has agreed terms to acquire the business and assets of Apex Laboratories Pty, a privately owned veterinary pharmaceutical company which manufactures, markets and sells branded non-proprietary prescription and other related companion animal products in Australia and New Zealand. The...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions